Liquidity & Technical

Figures converted from Indian Rupees (INR) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, RSI/MACD, realized-volatility percentages and traded-share counts are unitless and unchanged.

Liquidity & Technical

A USD 56.6-billion mega-cap with roughly USD 205 million of daily turnover — capacity is decisively not the constraint here, even for funds well over USD 4 billion at a 5% position weight. The technical picture is the more interesting story: HUL has spent ten months under its 200-day moving average after a death cross in July 2025, and price now sits 4.5% below trend with momentum just turning up from oversold — a tape that contradicts the "defensive bond proxy" narrative the fundamentals usually justify.

1 — Portfolio implementation verdict

2 — Price snapshot

Beta vs INDA / S&P-500 is not surfaced in the supplied dataset; the 30-day realized vol of 40.6% sits between the 5-year p20 (35.1%) and p50 (43.0%) — i.e. normal, not stressed. A realized vol that elevated in absolute terms is a function of the source price series being weekly-resampled; the relative-percentile reading is the cleaner signal.

3 — The critical chart: ten years of price vs 50d / 200d SMA

The lifetime view tells the story bluntly: HUL re-rated from ~$12 in 2016 to an all-time high of $33.99 on 20-Sep-2024 (a 2.8x in 8 years, after rupee-depreciation drag), then flat-lined and rolled over. The post-2024 plateau is the longest period in a decade where price has not made a new high — and price now sits roughly 29% below that ATH in dollar terms (the gap is wider than in INR because the rupee has weakened ~11% over the same 19 months). Regime: downtrend / sideways consolidation, with no golden cross in the trailing three years.

4 — Relative strength

Benchmark caveat: the supplied dataset names INDA (the broad-India ETF) as the reference but contains no INDA series, so a direct rebased comparison is not possible here. On a standalone INR basis HUL is flat over five years (rebased 100 → 102.7) — a 2.7% cumulative price return when the Nifty 50 is up roughly 75% over the same window. In USD terms the underperformance is even starker because the rupee has depreciated ~22% over five years, dragging dollar-denominated returns negative. The lag is severe: a chronic underperformer awaiting either a fundamental reset (volume growth returning) or a multiple compression that gets it to a buyable level.

5 — Momentum: RSI + MACD histogram

RSI made a textbook oversold bottom at 32.2 on 2-Apr-2026 — the deepest reading in the window — and has since rebuilt to a neutral 50.7. The MACD histogram tells the same story more sharply: it bottomed in early April and has flipped positive over the last three weeks (line crossed above signal). On a 1–3 month horizon momentum is constructively rising from oversold, but the absolute MACD line is still negative — so this is a counter-trend bounce, not a confirmed momentum re-acceleration. Reclaim of the 200d is what would convert the bounce into a trend change.

6 — Volume, sponsorship and volatility

Volume has run near-average across the entire 12 months (no sustained run above the 50-period mean). The April-2026 capitulation low was made on visibly elevated volume (13.4M and 14.8M shares the two weeks ending 10-Apr and 24-Apr) — that is a constructive selling-climax footprint that often precedes a tradable bounce, which is exactly what RSI/MACD then confirmed. There is no distribution signature on the way down (volume did not expand on the breakdown into the death cross), and no accumulation signature on the way back up — i.e. institutional sponsorship is neither aggressively exiting nor aggressively buying. This is a market in equilibrium, waiting for a fundamental catalyst.

Top 3 historical volume spikes

All three top volume events are 2020-COVID and 2024 election-week prints; nothing in the trailing twelve months breaks above 3× average, which reinforces the equilibrium read above. Catalyst column is left descriptive rather than speculative — no specific corporate filing is tied to any of these dates in the supplied research files.

Realized volatility — 5y view

Realized vol at 40.6% sits in the normal zone (between p20 of 35% and p50 of 43%). The market is not pricing crisis here. The reading is well below the 2022 stress regime (60–67%) but also below the depressed 2023–24 calm regime (28–33%) — the tape is in a "moderate uncertainty" range, consistent with a stock that has been re-rated lower but is no longer falling.

7 — Institutional liquidity panel

This section asks one question only: can a fund act in this stock at meaningful size, and at what cost? The answer is yes — comfortably.

A. ADV & turnover

Daily turnover of ~$205M on a $56.6B market cap is 0.36% / day — a healthy turnover ratio for an Indian mega-cap, especially with promoter Unilever PLC locking up ~62% of the float. Annual turnover of approximately 95% of shares outstanding signals deep institutional sponsorship rotation, not a closely-held illiquid name.

B. Fund-capacity table — what AUM can build a position?

Read the table this way: at a disciplined 20%-ADV participation cap, a fund managing up to USD 4.14 billion can build a 5% position in HUL inside one trading week. A more conservative 10%-ADV trader (the typical institutional execution desk for non-emergency adds) can support a fund up to USD 2.07 billion at the same 5% weight. For a long-only India equity fund, this means HUL is implementable at meaningful size in basically every realistic vehicle short of a multi-billion-dollar global EM mandate trying to take an overweight in one stop.

C. Liquidation runway — can you get out?

A 0.5%-of-mcap issuer-level position ($283M) clears inside one trading week at the aggressive 20% participation cap, and inside three weeks at the conservative 10% cap. A 1% position ($566M) needs nearly three weeks at 20% ADV and over a month at 10% ADV — that's the practical ceiling for "I can change my mind without becoming the market." Anything over 2% of market cap (>USD 1.1 billion) requires a multi-month exit horizon and crosses into block-trade / brokered-cross territory.

D. Execution friction proxy

The supplied dataset reports a median 60-day daily range of 0.0% — a nonsensical reading caused by the underlying source delivering open=high=low=close on each bar (i.e. weekly-resampled). I cannot rely on this metric. Cross-checking against the realized-vol percentile (p40-ish) and the implied 1-day ATR (roughly 1.5–2% based on the price range), HUL's intraday impact cost should sit comfortably under 25 bps for orders inside 10% of ADV — typical of Nifty-50 mega-caps. There is no friction red flag here.

8 — Technical scorecard + 3-to-6 month stance

Net technical score: −1 (modestly bearish).

Stance — 3 to 6 months

Neutral with a bearish tilt. HUL is in the eleventh month of a sub-200d downtrend; the tape has just produced a textbook oversold bounce off $22.02 with confirming RSI/MACD flips, but the 200-day at $25.26 is a hard ceiling that has not yet been challenged, and the stock has chronically underperformed the Nifty 50 over five years — that is not a setup that compels a long. The cleanest expression is to wait for either a directional break or a wider margin of safety:

• Bullish trigger (above): a weekly close above $25.26 (the 200-day SMA). That reclaim flips the trend regime, invalidates the death cross by definition, and opens a target at the prior $28.34 swing high and ultimately the $30.32–33.99 distribution top.
• Bearish trigger (below): a weekly close below $21.73 (the lower Bollinger band, also near recent April capitulation lows in the $22 area). That break re-engages the downtrend with the 52-week low near $20 as the next magnet.

Implementation note: liquidity is not the constraint — for any fund up to ~USD 4 billion, a 5% position is buildable in one trading week without becoming the market. The right action for that profile is watchlist with sized starter only above the 200d, full-size scale-in below $21.73 if and only if fundamentals corroborate a multiple reset. For larger global EM funds (>USD 5 B), build slowly over multiple weeks at the 10%-ADV cap — and price the 28-day exit horizon for a 1%-of-mcap exposure into the position-sizing decision.

---

Data note: source price series is weekly-resampled (~52 bars per year) rather than true daily. ADV and capacity figures should be read as the system-computed "per-session" outputs; cross-checking against exchange-published daily ADV (NSE/BSE) is recommended for execution sizing within tight tolerances. The relative-percentile and trend-direction conclusions above are unaffected by this caveat. Historical USD prices are translated from INR at period-appropriate FX rates; long-horizon returns reflect the combined effect of stock performance and rupee depreciation.